Provided by Tiger Trade Technology Pte. Ltd.

BAIYUNSHAN PH

18.870
+0.0300.16%
Volume:986.00K
Turnover:18.54M
Market Cap:30.68B
PE:10.82
High:18.890
Open:18.710
Low:18.690
Close:18.840
52wk High:20.400
52wk Low:15.014
Shares:1.63B
HK Float Shares:219.90M
Volume Ratio:0.94
T/O Rate:0.45%
Dividend:0.90
Dividend Rate:4.75%
EPS(LYR):1.744
ROE:7.97%
ROA:2.85%
PB:0.72
PE(LYR):10.82
PS:0.35

Loading ...

BAIYUNSHAN PH (00874): Subsidiary Baiyunshan Hanfang Receives Marketing Authorization for Structured Triglycerides Chemical Raw Material

Stock News
·
Aug 29, 2025

BAIYUNSHAN PH (00874): Guangzhou Pharmaceutical Sells Fourth Batch of Additional Basic Assets to Xingzheng Asset Management

Stock News
·
Aug 28, 2025

Guangzhou Baiyunshan Pharmaceutical - Disposals of Accounts Receivable

THOMSON REUTERS
·
Aug 28, 2025

Guangzhou Baiyunshan Pharmaceutical - Confirm Disposal of Fourth New Underlying Assets of Gp Corp for RMB502 Mln

THOMSON REUTERS
·
Aug 28, 2025

BAIYUNSHAN PH (00874): Completes Private Fund Registration

Stock News
·
Aug 19, 2025

Traditional Medicine Sector Under Pressure as Baiyunshan Faces Performance Challenges

Deep News
·
Aug 19, 2025

Baiyunshan Pharma's H1 Profit Slips 1%, Revenue Rises 2%; Hong Kong Shares Up 4%

MT Newswires Live
·
Aug 18, 2025

Hong Kong Stock Movement | BAIYUNSHAN PH (00874) Surges Nearly 5% as H1 Net Profit Declines 1.31% YoY While Health Segment Shows Strong Performance

Stock News
·
Aug 18, 2025

BAIYUNSHAN PH (00874) Appoints Chen Jiehui as Executive Director of Ninth Board of Directors

Stock News
·
Aug 15, 2025

BAIYUNSHAN PH (00874) to Distribute Interim Dividend of HK$0.4399 Per Share on September 26

Stock News
·
Aug 15, 2025

Guangzhou Baiyunshan Pharmaceutical - Proposes to Appoint Chen Jiehui as Executive Director of 9TH Session

THOMSON REUTERS
·
Aug 15, 2025

BAIYUNSHAN PH (00874) Reports First Half Results with Net Profit of ~2.516 Billion Yuan, Down 1.31% YoY

Stock News
·
Aug 15, 2025

Guangzhou Baiyunshan Pharmaceutical - to Pay an Interim Cash Dividend of RMB0.40 per Share

THOMSON REUTERS
·
Aug 15, 2025

Guangzhou Baiyunshan Pharmaceutical - Hy Operating Revenue RMB41.83 Bln

THOMSON REUTERS
·
Aug 15, 2025